I don't think we'll be adding a significant number
Post# of 72440
(Total Views: 868)
Posted On: 09/02/2017 12:00:12 PM
I don't think we'll be adding a significant number of shares to the outstanding count. Costs will drop significantly as the Prurisol and B-OM trials close out. I have no doubt we will strike a deal. It's simply a question of terms. P and B-OM will give us an idea of what we're dealing with and the best path forward will be determined at that point.
I expect we'll have all top line results in by Q1 2018 and at least one partnership/sale will occur some time in 2018. Hoping for some strong P results to get some stock appreciation prior to a deal.
The Kevetrin lotto ticket is also in play at this point - could be nothing or could be the greatest advancement in cancer treatment we've ever seen. Considering it is valued as nearly worthless by the market at this time, it is all upside on that one if we get any good results.
Go IPIX!
I expect we'll have all top line results in by Q1 2018 and at least one partnership/sale will occur some time in 2018. Hoping for some strong P results to get some stock appreciation prior to a deal.
The Kevetrin lotto ticket is also in play at this point - could be nothing or could be the greatest advancement in cancer treatment we've ever seen. Considering it is valued as nearly worthless by the market at this time, it is all upside on that one if we get any good results.
Go IPIX!
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.
Scroll down for more posts ▼